Ultrasonographic evaluation of changes in the muscle architecture of the gastrocnemius with botulinum toxin treatment for lower extremity spasticity in children with cerebral palsy

被引:14
|
作者
Kawano, Akihiro [1 ]
Yanagizono, Taiichiro [1 ]
Kadouchi, Ichiro [1 ]
Umezaki, Tetsuya [1 ]
Chosa, Etsuo [2 ]
机构
[1] Miyazaki Prefecture Ctr Disabled Children, Div Orthoped Surg, 4257-8 Kihara, Kiyotake, Miyazaki 8891601, Japan
[2] Univ Miyazaki, Fac Med, Div Orthoped Surg, Dept Med Sensory & Motor Organs, Miyazaki 8891692, Japan
关键词
MEDIAL GASTROCNEMIUS; FASCICLE LENGTH; IN-VIVO; VOLUME; CONTRACTIONS; RELIABILITY; INJECTION; ATROPHY; BIOPSY;
D O I
10.1016/j.jos.2017.10.012
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background: Botulinum toxin A treatment involves injecting botulinum toxin A to relax muscle spasticity. Using ultrasonography, this study examined changes in the muscle architecture before and after treatment to evaluate the influence of botulinum toxin A injection on muscles. Methods: The participants included 18 children (mean age, 6.2 years) with cerebral palsy who were treated with botulinum toxin A for lower extremity spasticity and 27 healthy children (mean age, 6.4 years) as a control group. In all cases, botulinum toxin A was injected into the gastrocnemius muscle. The muscle length, muscle width, and pennation angle (which indicates the degree of muscle fiber tone), were measured using B-mode ultrasonography before and 12 weeks after injection. Results: The muscle length and muscle width were shorter in the cerebral palsy group than in the control group. The pennation angle in the cerebral palsy group significantly decreased after injection from 28.2 +/- 3.6 degrees to 25.8 +/- 2.5 degrees in the resting position of the ankle and from 18.6 +/- 2.8 degrees to 15.9 +/- 1.7 degrees in the maximum dorsiflexion position of the ankle. In the control group, the pennation angle was 25.9 +/- 3.2 degrees in the resting position of the ankle and 15.1 +/- 2.5 degrees in the maximum dorsiflexion position of the ankle. The rate of increase of fascicle length during passive movement from the resting position of the ankle to the maximum dorsiflexion position was 143.9% in the cerebral palsy group, which was significantly less than the value of 157.7% in the control group. After botulinum toxin A treatment, the rate of increase of fascicle length in the cerebral palsy group increased to 155.1%. Conclusions: The decrease in the pennation angle after botulinum toxin A treatment is considered to be the result of a reduction of spasticity and subsequent structural changes in flaccid muscle fibers. (C) 2017 The Japanese Orthopaedic Association. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:389 / 393
页数:5
相关论文
共 50 条
  • [1] Botulinum toxin type A in the treatment of lower limb spasticity in children with cerebral palsy
    Blumetti, Francesco C.
    Belloti, Joao Carlos
    Tamaoki, Marcel J. S.
    Pinto, Josa A.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (10):
  • [2] Botulinum toxin for spasticity in children with cerebral palsy: A comprehensive evaluation
    Bjornson, Kristie
    Hays, Ross
    Graubert, Cathy
    Price, Robert
    Won, Francine
    McLaughlin, John F.
    Cohen, Morty
    PEDIATRICS, 2007, 120 (01) : 49 - 58
  • [3] Botulinum toxin type A in the treatment of lower-limb spasticity in children with cerebral palsy
    Camargo, C. H. F.
    Teive, H. A. G.
    Munhoz, R. P.
    Zonta, M.
    Silva, G. C.
    Becker, N.
    Werneck, L. C.
    MOVEMENT DISORDERS, 2009, 24 : S450 - S450
  • [4] Botulinum toxin type A in the treatment of lower-limb spasticity in children with cerebral palsy
    Teive, H.
    Munhoz, R. P.
    Becker, N.
    Werneck, L. C.
    Zonta, M.
    Camargo, C. H. F.
    Moscovich, M.
    Filla, L.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S47 - S47
  • [5] BOTULINUM TOXIN TYPE A IN THE TREATMENT OF LOWER-LIMB SPASTICITY IN CHILDREN WITH CEREBRAL PALSY
    Camargo, Carlos Henrique F.
    Teive, Helio A. G.
    Zonta, Marise
    Silva, Gilmar C.
    Oliveira, Marcelo R.
    Roriz, Mauricio M.
    Brandi, Ivar V.
    Becker, Nilson
    Scola, Rosana Herminia
    Werneck, Lineu Cesar
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2009, 67 (01) : 62 - 68
  • [6] Potential of Botulinum toxin A to treat upper extremity spasticity in children with cerebral palsy
    Nikaina, Irene
    Papavasiliou, Antigone
    TOXIN REVIEWS, 2014, 33 (03) : 107 - 118
  • [7] Botulinum toxin A in treatment of cerebral palsy spasticity
    Carrelet, P
    Bollini, G
    Mancini, J
    Chabrol, B
    ARCHIVES DE PEDIATRIE, 2002, 9 (09): : 928 - 933
  • [8] Treatment of spasticity in cerebral palsy with botulinum toxin
    Calderón-González, R
    Calderón-Sepúlveda, RF
    REVISTA DE NEUROLOGIA, 2002, 34 (01) : 52 - 59
  • [9] Architectural Changes of the Gastrocnemius Muscle after Botulinum Toxin Type A Injection in Children with Cerebral Palsy
    Park, Eun Sook
    Sim, Eungeol
    Rha, Dong-Wook
    Jung, Soojin
    YONSEI MEDICAL JOURNAL, 2014, 55 (05) : 1406 - 1412
  • [10] High dose botulinum toxin A for the treatment of lower extremity hypertonicity in children with cerebral palsy
    Willis, Allison W.
    Crowner, Beth
    Brunstrom, Janice E.
    Kissel, Abigail
    Racette, Brad A.
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2007, 49 (11): : 818 - 822